ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

AFLIBERCEPTUM

Active substance (INN) · ATC S01LA05 · 9 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
L01XX44	AFLIBERCEPTUM	In force	medicine of the protocol	C2-P3	NO
S01LA05	AFLIBERCEPTUM	In force	medicine of the protocol	C1-G26	NO

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
AFQLIR 40 mg/ml	SOL. INJ.	40mg/ml	SANDOZ GMBH - AUSTRIA	S01LA05	PR
AFQLIR 40 mg/ml	SOL. INJ. IN SERINGA PREUMPLUTA	40mg/ml	SANDOZ GMBH - AUSTRIA	S01LA05	PR
AHZANTIVE 40 mg/ml	SOL. INJ. IN SERINGA PREUMPLUTA	40mg/ml	FORMYCON AG - GERMANIA	S01LA05	PR
EYDENZELT 40 mg/ml	SOL. INJ.	40mg/ml	CELLTRION HEALTHCARE HUNGARY KFT. - UNGARIA	S01LA05	PR
EYDENZELT 40 mg/ml	SOL. INJ. IN SERINGA PREUMPLUTA	40mg/ml	CELLTRION HEALTHCARE HUNGARY KFT. - UNGARIA	S01LA05	PR
EYLEA 114,3 mg/ml	SOL. INJ.	114,3mg/ml	BAYER AG - GERMANIA	S01LA05	PR
EYLEA 114,3 mg/ml	SOL. INJ. IN SERINGA PREUMPLUTA	114,3mg/ml	BAYER AG - GERMANIA	S01LA05	PR
EYLEA 40 mg/ml	SOL. INJ.	40mg/ml	BAYER AG - GERMANIA	S01LA05	PR
EYLEA 40 mg/ml	SOL. INJ. IN SERINGA PREUMPLUTA	40mg/ml	BAYER AG - GERMANIA	S01LA05	PR
MYNZEPLI 40 mg/ml	SOL. INJ.	40mg/ml	ADVANZ PHARMA LIMITED - IRLANDA	S01LA05	PR
MYNZEPLI 40 mg/ml	SOL. INJ. IN SERINGA PREUMPLUTA	40mg/ml	ADVANZ PHARMA LIMITED - IRLANDA	S01LA05	PR
OPUVIZ 40 mg/ml	SOL. INJ.	40mg/ml	SAMSUNG BIOEPIS NL B.V. - OLANDA	S01LA05	PR
PAVBLU 40 mg/ml	SOL. INJ.	40mg/ml	AMGEN TECHNOLOGY (IRELAND) UC - IRLANDA	S01LA05	PR
PAVBLU 40 mg/ml	SOL. INJ. IN SERINGA PREUMPLUTA	40mg/ml	AMGEN TECHNOLOGY (IRELAND) UC - IRLANDA	S01LA05	PR
ZALTRAP 25 mg/ml	CONC. PT. SOL. PERF.	25mg/ ml	SANOFI WINTHROP INDUSTRIE - FRANTA	L01XX44	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.